Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jeff Leiden
Age : 65
Public asset : 20,114,790 USD
Country of residence : Unknown
Linked companies : Vertex Pharmaceuticals Incorporated - Revolution Healthcare Acquisition Corp.

Biography of Jeff Leiden 
Jeffrey M. Leiden is a businessperson who founded CardioGene Therapeutics, Inc. and who has been at the head of 11 different companies. Dr. Leiden occupies the position of Executive Chairman of Vertex Pharmaceuticals, Inc., Non-Executive Chairman at Tmunity Therapeutics, Inc., Chairman at PathAI, Inc., Chairman for Casana Care, Inc. and Chairman of Revolution Healthcare Acquisition Corp. He is also Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Member of Association of American Physicians, Member of American Society of Clinical Investigation and Member of National Academy of Medicine of United States and on the board of 6 other companies. In the past Dr. Leiden was Chairman at Lycera Corp., President & Chief Operating Officer of Abbott Laboratories, Chairman of TYRX, Inc., Chairman at Variation Biotechnologies (US), Inc., Managing Director at Clarus Ventures LLC, President & Chief Operating Officer at Pharmaceutical Products, Member of National Heart, Lung & Blood Institute, Chief Cardiology Officer at The University of Chicago, Professor at Harvard Medical School and Professor-Biological Sciences at Harvard T.H. Chan School of Public Health. He received a doctorate and an undergraduate degree from The University of Chicago.


Current positions of Jeff Leiden 
Holdings of Jeff Leiden 
Jeff Leiden : Personal Network 
Most Read News 
06/22ELON MUSK : Musk says Tesla's new car factories 'losing billions of dollars'
RE
06/15ELON MUSK : Elon Musk appeals decision concerning SEC settlement over Twitter posts
RE
06/23MARK MILLER : Column-Want to do something about your ailing retirement savings? Don't
RE
06/13ELON MUSK : Musk to attend Twitter staff Q&A meet for first time since launching bid
RE
06/22TREVOR MILTON : Nikola founder Trevor Milton faces new fraud charge
RE
06/13BENEDETTO VIGNA : Vigna to set out Ferrari's route into electric vehicle era
RE
06/22RUPERT MURDOCH : Rupert Murdoch and Jerry Hall are getting a divorce - NYT
RE
06/15PETER WENNINK : Samsung's Lee discusses smooth supply of "essential" chip equipment with ASML's Wennink
RE
06/14HAROLD HAMM : Billionaire-founder Harold Hamm offers to take Continental private in $25-billion deal
RE
06/21ELON MUSK : Musk says there are still a few unresolved matters with Twitter deal
RE
More news


© 2022 People and Ownership :   
Jeff Leiden : Connections 


Latest news about Jeff Leiden 
05/17Vertex Pharmaceuticals Incorporated Announces Further Expansion in the Boston Seaport At Dedication of the Jeffrey Leiden Center for Cell and Genetic Therapies
CI
2021Meatable B.V. announced that it has received $47 million in funding from BY Capital Management GmbH, Agronomics Limited, Humboldt Fund, DSM Venturing, Section 32, and other investors
CI
2020VERTEX PHARMACEUTICALS : Shares Plunge After Biotech Drops Closely Watched Drug Prospect
DJ
2020TRANSCRIPT : Vertex Pharmaceuticals Incorporated, Q4 2019 Earnings Call, Jan 30, 2020
CI
2020TRANSCRIPT : Vertex Pharmaceuticals Incorporated Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 11:30 AM
CI
2019TRANSCRIPT : Vertex Pharmaceuticals Incorporated Presents at Credit Suisse 28th Annual Healthcare Conference, Nov-12-2019 11:30 AM
CI
2019TRANSCRIPT : Vertex Pharmaceuticals Incorporated, Q3 2019 Earnings Call, Oct 30, 2019
CI
More news